| Literature DB >> 30804900 |
Sun Ae Kim1, Min Ji Jang1, Seo Young Kim1, Yichao Yang2, Hilary O Pavlidis3, Steven C Ricke4.
Abstract
Campylobacter as an inhabitant of the poultry gastrointestinal tract has proven to be difficult to reduce with most feed additives. In-feed antibiotics have been taken out of poultry diets due to the negative reactions of consumers along with concerns regarding the generation of antibiotic resistant bacteria. Consequently, interest in alternative feed supplements to antibiotics has grown. One of these alternatives, prebiotics, has been examined as a potential animal and poultry feed additive. Prebiotics are non-digestible ingredients by host enzymes that enhance growth of indigenous gastrointestinal bacteria that elicit metabolic characteristics considered beneficial to the host and depending on the type of metabolite, antagonistic to establishment of pathogens. There are several carbohydrate polymers that qualify as prebiotics and have been fed to poultry. These include mannan-oligosaccharides and fructooligosaccharides as the most common ones marketed commercially that have been used as feed supplements in poultry. More recently, several other non-digestible oligosaccharides have also been identified as possessing prebiotic properties when implemented as feed supplements. While there is evidence that prebiotics may be effective in poultry and limit establishment of foodborne pathogens such as Salmonella in the gastrointestinal tract, less is known about their impact on Campylobacter. This review will focus on the potential of prebiotics to limit establishment of Campylobacter in the poultry gastrointestinal tract and future research directions.Entities:
Keywords: Campylobacter; gastrointestinal tract; poultry; prebiotics; synbiotics
Year: 2019 PMID: 30804900 PMCID: PMC6371025 DOI: 10.3389/fmicb.2019.00091
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Campylobacter in the poultry gastrointestinal tract.
| Poultry | Sample | Sample number | Prevalence of | Reference | |
|---|---|---|---|---|---|
| Market-age broiler chickens | Ceca | 240 | 9 samples positive (3.8%) | – | |
| Crop | 359 | 224 samples positive (62.4%) | – | ||
| New York-dressed broiler | Ceca | 128 (32 birds ∗ 4 repetition) | 128 samples positive (100%) with direct plating 81 sample positive (63%) after enrichment | 6.8 | |
| Crop | 128 (32 birds ∗ 4 repetition) | 122 samples positive (95.3%) with direct plating 127 samples positive (99.2%) after enrichment | 3.7 | ||
| Market-weight turkey | Ceca | 84 | 2 samples | – | |
| 96 samples | – | ||||
| Crop | 96 | 11 samples | – | ||
| 61 samples | – | ||||
| Turkey during slaughtering | Ceca at evisceration step | 30 (collected on July) | 30 samples positive (100%) | 6.0 | |
| 30 (collected on Sep) | 22 samples positive (73.3%) | 2.1 | |||
| 30 (collected on Oct) | 30 samples positive (100%) | 7.2 | |||
| 30 (collected on Nov) | 30 samples positive (100%) | 6.0 | |||
| Chicken | Ceca | 24 | – | 8.5 | |
| Crop | 23 | – | 4.8 | ||
| Chicken | Gizzard | 4 male | – | 2.5 | |
| 4 female | – | 2.5 | |||
| Small Intestine | 4 male | – | 3.6 | ||
| 4 female | – | 3.8 | |||
| Large intestine | 4 male | – | 5.3 | ||
| 4 female | – | 5.4 | |||
| Cecal intestine | 4 male | – | 5.3 | ||
| 4 female | – | 4.4 | |||
Impact of prebiotics as feed additive on Campylobacter counts in poultry gastrointestinal tract.
| Prebiotic treatment | Tested GIT | Changes in | Reference | |
|---|---|---|---|---|
| Feed with 0.1% xylanase (Avizyme-1300) | Cecal, sall intestine, and large intestine | Direct plating | ||
| Feed with 1.0% inulin (Raftifeed®IPF) Feed with 1.0% oligofructose (Raftifeed®OPS) | Fecal, gizzard, small intestine, large intestine, and cecal intestine | Direct plating | ||
| Feed with 0.2% mannan-oligosaccharides Feed with 0.5% mannan-oligosaccharides | Cecal intestine | Direct plating | ||
| Feed with 0.2% Biolex®MB40 Feed with 0.2% Leiber®ExCel | Cecal intestine | Direct plating | ||
| Probiotics (isolate 1, 2, or 3) + prebiotics (0.125, 0.25, or 0.5% fructooligosaccharide or 0.04, 0.08, or 0.16% manna-oligosaccharides) | Cecal intestine | Direct plating | ||
| Feed with 0.125% prebiotic-like product (Original XPCTM) | Cecal intestine | Direct plating | ||
| Feed supplemented with 0.5 and 1% oligosaccharides extract from palm kernel expeller (OligoPKE) | Cecal intestine | Quantitative real time PCR | No significant changes in | |
| Feed with 0.2% β-glucan and mannan-oligosaccharides (Biolex®MB40) | Cecal intestine | Next generation sequencing with Illumina MiSeq | No significant changes in the relative abundance of | |
| Feed with 0.1% plum fibers Feed with 0.1% fructooligosaccharides Feed with 0.2% galactooligosaccharides | Cecal intestine | Direct plating | No significant changes in | |